Add BrightSurf on Google Email

The dance of the chaperones

Researchers have identified DnaK as a central player in the chaperone network of E. coli, which helps proteins fold into their complex three-dimensional structures. This discovery sheds light on the mechanisms behind protein folding and has implications for understanding diseases such as Alzheimer's and Parkinson's.

SourceMax-Planck-Gesellschaft·JournalCell Reports·DateMar 8, 2012

Protein assassin

Scientists have found that the unfolded end of a protein, ColN-T, can still kill E. coli-like bacteria even after its toxic folded portion is removed. This discovery may lead to new, targeted ways to kill antibiotic-resistant microbes.

A step closer to understanding, averting drug resistance

Researchers at Brandeis University have made a significant discovery on how EmrE, a protein responsible for exporting antibiotics from cells, works. By studying its structure and function using nuclear magnetic resonance spectroscopy, the team hopes to develop inhibitors that can target this protein and prevent drug resistance.

SourceBrandeis University·JournalNature·DateFeb 1, 2012

Viruses con bacteria into working for them

Researchers discovered that certain ocean bacteria are tricked into using their own machinery to activate genes carried by viruses. The viruses inject DNA into stressed bacteria, which then support the virus' replication cycle. This co-evolutionary relationship reveals a sophisticated mechanism of gene regulation and exploitation.

New discoveries in cell aging

Scientists have developed a reliable system to model and quantify protein aggregation's impact on cell viability, division, and aging. The study uses Escherichia coli bacteria and the AB42 peptide to predict protein aggregation's effects on cell aging, revealing potential natural chaperones that reduce this damage.

SourceUniversitat Autonoma de Barcelona·JournalJournal of Molecular Biology·DateJan 23, 2012

News tips from the journal mBio

A recent study in the journal mBio challenges the unique E. coli protein YfeX's role in iron acquisition, finding it lacks catalytic ability to dechelate iron from heme. Meanwhile, researchers discover an unprecedented level of transference of resistance among strains and species of bacteria via plasmids containing carbapenemase genes.

Researchers unlock bacteria's beneficial side

Phosphonic acids are persistent pollutants found in common medicinal products, detergents, and herbicides. Bacteria have been shown to break down these molecules with surprising ease, thanks to the identification of specialized proteins that perform key bond-breaking steps.

SourceQueen's University·JournalProceedings of the National Academy of Sciences·DateNov 24, 2011

JCI online early table of contents: November 1, 2011

Scientists discover a possible therapy for hereditary sensory and autonomic neuropathy type 1, reversing toxic molecule accumulation in mice. Additionally, researchers design minihepcidins to reduce iron overload by mimicking the natural protein's ability to lower blood iron levels.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateNov 1, 2011

Geoscientists find key to why some patients get infections from cardiac implants

Researchers found that certain strains of Staphylococcus aureus bacteria have genetic variants that enable them to form biofilms on cardiac devices. This discovery offers clues for preventing infections in patients with implanted devices, which currently cost thousands of dollars and millions of dollars in healthcare costs each year.

SourceU.S. National Science Foundation·JournalProceedings of the National Academy of Sciences·DateOct 25, 2011

Bionic bacteria may help fight disease and global warming

Researchers at Salk Institute developed bacteria that can incorporate unnatural amino acids into proteins, enabling the creation of new synthetic chemicals. This breakthrough may lead to the development of drugs that last longer in the bloodstream and environmentally friendly manufacturing methods.

SourceSalk Institute·JournalNature Chemical Biology·DateSep 21, 2011

Yale researchers use genetic code to engineer a living protein

Researchers at Yale University have successfully re-engineered the genetic code of bacteria to synthesize special forms of proteins that can mimic natural or disease states. This new technology enables the production of human proteins with their naturally occurring phosphorylation sites, a crucial step in understanding disease processes.

SourceYale University·JournalScience·DateAug 25, 2011

New cell type offers immunology hope

Australian scientists have identified a new type of NKT cell that can specifically target lipids found in bacterial cell walls, offering hope for novel vaccine development. The discovery provides insight into the immune system's unique function and its potential to combat various diseases.

SourceUniversity of Melbourne·JournalNature Immunology·DateJun 13, 2011

Bacterial roundabouts determine cell shape

Researchers found that MreB proteins assemble into patches and move in circular paths along the inside of the cell membrane, relying on a functioning cell wall for movement. This discovery opens up new avenues for therapeutic intervention and could lead to urgently needed alternatives to antibiotics.

SourceMax-Planck-Gesellschaft·JournalScience·DateJun 3, 2011